These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7903213)

  • 1. The effects of tertatolol on lipid profile.
    Diehm C; Jacobsen O; Amendt K
    Cardiology; 1993; 83 Suppl 1():32-40. PubMed ID: 7903213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of clinical safety and efficacy of tertatolol.
    Vivet P
    Cardiology; 1993; 83 Suppl 1():41-50. PubMed ID: 7903214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term experience with tertatolol in hypertension.
    Komajda M; Genevray B; Grosgogeat Y
    Am J Nephrol; 1986; 6 Suppl 2():106-12. PubMed ID: 2879465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. European experience with artex: the Tertatolol International Multicentre Study (TIMS).
    Laher MS
    Cardiology; 1993; 83 Suppl 1():25-31. PubMed ID: 7903212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of long-term antihypertensive treatment with tertatolol on diastolic function in hypertensive patients with and without left ventricular hypertrophy.
    Trimarco B; DeLuca N; Rosiello G; Ricciardelli B; Marchegiano R; Condorelli G; Raponi M; Condorelli M
    Am J Hypertens; 1989 Nov; 2(11 Pt 2):278S-283S. PubMed ID: 2573376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive effects of tertatolol: 3-month comparative study against acebutolol.
    Gallet M; Kleinknecht D; Maurice P
    Am J Nephrol; 1986; 6 Suppl 2():83-7. PubMed ID: 2879477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Tertatolol International Multicenter Study (T.I.M.S.). Predicting factors of an efficient therapy.
    Agnes E; Vandermercken C; Prost JF; Safar ME
    Am J Hypertens; 1989 Nov; 2(11 Pt 2):296S-302S. PubMed ID: 2573379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive effects of tertatolol. A comparative study versus atenolol.
    Mota JC; Carrageta MD; Felix S; Nunes AM; Jobbé-Duval M
    Am J Hypertens; 1989 Nov; 2(11 Pt 2):284S-288S. PubMed ID: 2573377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of carvedilol and metoprolol on serum lipid concentration in diabetic hypertensive patients.
    Bell DS; Bakris GL; McGill JB
    Diabetes Obes Metab; 2009 Mar; 11(3):234-8. PubMed ID: 18564334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tertatolol in hypertension. Long-term therapy in 2,338 patients.
    Guery O; Herpin D; Lecasble M; Piron J
    Am J Hypertens; 1989 Nov; 2(11 Pt 2):289S-295S. PubMed ID: 2573378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular response to adrenergic stimulation during treatment with tertatolol. A new non-cardioselective beta-blocking agent in primary hypertensive patients.
    Fasano ML; Gaeta I; De Simone G; Iannuzzi R; Ferrara LA
    Jpn Heart J; 1991 Jul; 32(4):435-44. PubMed ID: 1683411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-Blockers in patients with intermittent claudication and arterial hypertension: results from the nebivolol or metoprolol in arterial occlusive disease trial.
    Espinola-Klein C; Weisser G; Jagodzinski A; Savvidis S; Warnholtz A; Ostad MA; Gori T; Munzel T
    Hypertension; 2011 Aug; 58(2):148-54. PubMed ID: 21646599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tertatolol does not affect biochemical markers of atherosclerosis in normo- and hyperlipidemic hypertensive patients.
    Richard JL; Martin C; Jacotot B
    Am J Nephrol; 1986; 6 Suppl 2():100-5. PubMed ID: 2879464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of tertatolol in hypertensive patients with chronic renal failure.
    Beaufils M; Lantz B; Paillard F; Richet G
    Am J Nephrol; 1986; 6 Suppl 2():50-4. PubMed ID: 2879474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of novel renal properties of tertatolol.
    Guillet C
    Cardiology; 1993; 83 Suppl 1():64-9. PubMed ID: 7903218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative renal and cardiac effects of tertatolol and enalapril in essential hypertension.
    Ribstein J; Du Cailar G; Brouard R; Mimran A
    Cardiology; 1993; 83 Suppl 1():57-63. PubMed ID: 7903217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of carvedilol and metoprolol on serum lipid concentrations and symptoms in patients with hyperthyroidism.
    Ozbilen S; Eren MA; Turan MN; Sabuncu T
    Endocr Res; 2012; 37(3):117-23. PubMed ID: 22571552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additional benefits of combining beta-blockade and renal vasodilation in the treatment of mild to moderate hypertension: Tertatolol International Multicentre Study results.
    Agnes E; Prost JF; Laher MS
    J Hypertens Suppl; 1989 Dec; 7(6):S270-1. PubMed ID: 2576668
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients with type 2 diabetes mellitus and mild hypertension: a sequential, randomized, double-blind clinical trial.
    Derosa G; Cicero AF; D'Angelo A; Fogari E; Salvadeo S; Gravina A; Ferrari I; Fassi R; Fogari R
    Clin Ther; 2007 Apr; 29(4):602-10. PubMed ID: 17617283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the antihypertensive and renal effects of tertatolol and nadolol in hypertensive patients with mild renal impairment.
    Fallo F; Gregianin M; Bui F; Macrì C; Folino P; Mantero F
    Eur J Clin Pharmacol; 1991; 40(3):309-11. PubMed ID: 1676368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.